FR09C0040I2 - - Google Patents
Info
- Publication number
- FR09C0040I2 FR09C0040I2 FR09C0040C FR09C0040C FR09C0040I2 FR 09C0040 I2 FR09C0040 I2 FR 09C0040I2 FR 09C0040 C FR09C0040 C FR 09C0040C FR 09C0040 C FR09C0040 C FR 09C0040C FR 09C0040 I2 FR09C0040 I2 FR 09C0040I2
- Authority
- FR
- France
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
- C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D223/18—Dibenzazepines; Hydrogenated dibenzazepines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
- C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D223/18—Dibenzazepines; Hydrogenated dibenzazepines
- C07D223/22—Dibenz [b, f] azepines; Hydrogenated dibenz [b, f] azepines
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicinal Preparation (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PT101732A PT101732B (en) | 1995-06-30 | 1995-06-30 | SUBSTITUTED AZEPINES PROCESS FOR THE PREPARATION OF THE PHARMACEUTICAL COMPOSITIONS CONTAINED THEREOF AND USES OF THE NEW COMPOUNDS IN THE PREPARATION OF PHARMACEUTICAL COMPOSITIONS EMPLOYED IN DISEASES OF THE NERVOUS SYSTEM |
Publications (2)
Publication Number | Publication Date |
---|---|
FR09C0040I1 FR09C0040I1 (en) | 2009-10-30 |
FR09C0040I2 true FR09C0040I2 (en) | 2011-04-01 |
Family
ID=20085522
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR09C0040C Active FR09C0040I2 (en) | 1995-06-30 | 2009-08-26 |
Country Status (22)
Country | Link |
---|---|
US (1) | US5753646A (en) |
EP (1) | EP0751129B3 (en) |
JP (2) | JP3852984B2 (en) |
KR (1) | KR100376603B1 (en) |
CN (1) | CN1070853C (en) |
AR (1) | AR003962A1 (en) |
AT (1) | ATE173468T3 (en) |
AU (1) | AU705388B2 (en) |
BR (1) | BRPI9602933B8 (en) |
CA (1) | CA2180301C (en) |
DE (2) | DE69600985T3 (en) |
DK (1) | DK0751129T6 (en) |
ES (1) | ES2124612T7 (en) |
FR (1) | FR09C0040I2 (en) |
HU (1) | HU221382B1 (en) |
NL (1) | NL300406I1 (en) |
PL (1) | PL185476B1 (en) |
PT (1) | PT101732B (en) |
RU (1) | RU2168502C2 (en) |
SI (1) | SI0751129T1 (en) |
TR (1) | TR199701734T1 (en) |
WO (1) | WO1997002250A1 (en) |
Families Citing this family (46)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9930058D0 (en) | 1999-12-20 | 2000-02-09 | Novartis Ag | Organic compounds |
GB0111566D0 (en) * | 2001-05-11 | 2001-07-04 | Portela & Ca Sa | Method for preparation of (s)-(+)-and (r)-(-)-10,11-dihydro-10-hydroxy-5h-dibenz/b,f/azephine-5-carboxamide |
GB0112812D0 (en) * | 2001-05-25 | 2001-07-18 | Portela & Ca Sa | Mthd for preparation of 10, 11-dihydro-10-hydroxy-5H-dibenz/B,F/azepine-5-c arboxamide and 10,11-dihydro-10-oxo-5H-dibenz/B,F/azepine-5-carb oxamide therefrom |
CA2463970A1 (en) * | 2001-11-12 | 2003-05-22 | Novartis Ag | Monohydroxycarbamazepine for use in the preparation of a medicament for the treatment of affective and attention disorder and neuropathic pain |
CN1674909A (en) * | 2002-08-06 | 2005-09-28 | 诺瓦提斯公司 | Use of carboxamides for the treatment of tinnitus |
GB0223224D0 (en) * | 2002-10-07 | 2002-11-13 | Novartis Ag | Organic compounds |
EP1596866A2 (en) * | 2003-02-17 | 2005-11-23 | Novartis AG | Use of s-10 hydroxy-10, 11-dihydro-carbamazepine for the treatment of anxiety and bipolar disorders |
GB0303613D0 (en) * | 2003-02-17 | 2003-03-19 | Novartis Ag | Use of organic compounds |
TW200501962A (en) * | 2003-04-01 | 2005-01-16 | Novartis Ag | Use of carbamazepine derivatives for the treatment of agitation in dementia patients |
TW200502222A (en) | 2003-04-02 | 2005-01-16 | Novartis Ag | Use of 10-hydroxy-10,11-dihydrocarbamazepine derivatives for the treatment of affective disorders |
GB2401605A (en) * | 2003-05-12 | 2004-11-17 | Portela & Ca Sa | Method for racemisation of (S)-(+)- and (R)-(-)-10,11-dihydro-10-hydroxy-5H-dibenz[b,f]azepine-5-carboxamide and optically enriched mixtures thereof |
GB2416167A (en) * | 2004-07-13 | 2006-01-18 | Portela & Ca Sa | Chiral inversion and esterification of (S)- and (R)-10-hydroxy-dibenzazepine carboxamides |
ITMI20042230A1 (en) * | 2004-11-19 | 2005-02-19 | Farchemia Srl | PROCEDURE FOR THE PREPARATION OF 10,11-DIIDRO-10 HYDROXY-5H-DIBENZ-B, F-AZEPIN-5CARBOSSIAMMIDE |
GB2422149A (en) * | 2005-01-14 | 2006-07-19 | Portela & Ca Sa | Process for the preparation of 10,11-dihydro-10-hydroxy-5H-dibenz[b,f]azepine-5-carboxamide |
GB0507298D0 (en) | 2005-04-11 | 2005-05-18 | Novartis Ag | Organic compounds |
US20060252745A1 (en) * | 2005-05-06 | 2006-11-09 | Almeida Jose L D | Methods of preparing pharmaceutical compositions comprising eslicarbazepine acetate and methods of use |
MX2007013882A (en) * | 2005-05-06 | 2008-01-28 | Portela & Ca Sa | Methods of preparing pharmaceutical compositions comprising eslicarbazepine acetate and methods of use. |
EP2380573B1 (en) * | 2005-05-06 | 2015-02-25 | Bial-Portela & CA, S.A. | Eslicarbazepine acetate and methods of use |
GB0515690D0 (en) | 2005-07-29 | 2005-09-07 | Portela & Ca Sa | Asymmetric catalytic reduction |
GB0517740D0 (en) * | 2005-08-31 | 2005-10-12 | Novartis Ag | Organic compounds |
GB0603008D0 (en) * | 2006-02-14 | 2006-03-29 | Portela & Ca Sa | Method |
GB2437078A (en) * | 2006-04-11 | 2007-10-17 | Portela & Ca Sa | 10-Acyloxy-5H-dibenzo[b,f]azepine-5-carboxamides & their asymmetric hydrogenation to the chiral 10,11-dihydro derivatives |
GB0700773D0 (en) | 2007-01-15 | 2007-02-21 | Portela & Ca Sa | Drug therapies |
US8372431B2 (en) | 2007-10-26 | 2013-02-12 | Bial-Portela & C.A., S.A. | Pharmaceutical composition comprising licarbazepine acetate |
EP2414335A2 (en) | 2009-04-02 | 2012-02-08 | Glenmark Generics Limited | A process for the purification of eslicarbazepine acetate |
EP2459198A1 (en) * | 2009-07-27 | 2012-06-06 | Bial-Portela & CA, S.A. | Use of 5h-dibenz / b, f/ azepine-5-carboxamide derivatives for treating fibromyalgia |
WO2011045648A2 (en) | 2009-10-12 | 2011-04-21 | Matrix Laboratories Limited | Process for preparing (s)-(-)-10-acetoxy-10,11-dihydro-5h-dibenz[b,f]azepine-5-carboxamide and its esters thereof |
WO2011091131A2 (en) * | 2010-01-23 | 2011-07-28 | Dr. Reddy's Laboratories Ltd. | Eslicarbazepine acetate and its polymorphs |
WO2011117885A1 (en) * | 2010-03-23 | 2011-09-29 | Intas Pharmaceuticals Limited | Process for preparation of enantiomers of licarbazepine |
EP2383261B1 (en) | 2010-04-23 | 2013-09-04 | Euticals GmbH | Process for the asymmetric hydrogenation of ketones |
WO2011138795A2 (en) * | 2010-05-03 | 2011-11-10 | Msn Laboratories Limited | Process for preparing (s)-10-acetoxy-10,11-dihydro-5h-dibenz[b,f] azepine-5-carboxamide |
MX350531B (en) | 2010-12-31 | 2017-09-08 | BIAL PORTELA & Cª S A | Granulates comprising eslicarbazepine acetate. |
WO2012121701A1 (en) * | 2011-03-07 | 2012-09-13 | Watson Laboratories, Inc. | Process for the resolution of racemic (±)-10,11-dihydro-10-hydroxy-5h-dibenz[b,f]azepine-5-carboxamide |
US9346760B2 (en) | 2011-03-08 | 2016-05-24 | Jubilant Life Sciences Limited | Process for the preparation of (S)-(+)- or (R)-(-)-10-hydroxy dihydrodibenz[B,F]azepines by enantioselective reduction of 10,11-dihydro-10-OXO-5H-dibenz[B,F]azepines and polymorphs thereof |
WO2012142302A2 (en) | 2011-04-13 | 2012-10-18 | Codexis, Inc. | Biocatalytic process for preparing eslicarbazepine and analogs thereof |
US20150065704A1 (en) | 2011-07-13 | 2015-03-05 | Ketan Hirpara | Process for the preparation and purification of eslicarbazepine acetate and intermediates thereof |
WO2013032351A1 (en) | 2011-08-26 | 2013-03-07 | BIAL - PORTELA & Cª, S.A. | Treatments involving eslicarbazepine acetate or eslicarbazepine |
CN104350041A (en) * | 2012-05-07 | 2015-02-11 | 塞利克斯比奥私人有限公司 | Compositions and methods for the treatment of neurological disorders |
US20150232426A1 (en) | 2012-09-26 | 2015-08-20 | Ranbaxy Laboratories Limited | Process for the preparation of oxcarbazepine and its use as intermediate in the preparation of eslicarbazepine acetate |
NZ736131A (en) * | 2014-09-26 | 2019-04-26 | Cellix Bio Private Ltd | Compositions and methods for the treatment of epilepsy and neurological disorders |
CN105384689B (en) * | 2014-12-24 | 2017-10-31 | 开封制药(集团)有限公司 | A kind of synthetic method of improved eslicarbazepine acetate |
EP3064490A1 (en) | 2015-03-06 | 2016-09-07 | F.I.S.- Fabbrica Italiana Sintetici S.p.A. | Improved process for the preparation of eslicarbazepine and eslicarbazepine acetate |
CN105130899A (en) * | 2015-08-25 | 2015-12-09 | 安徽省新星药物开发有限责任公司 | Synthetic method for eslicarbazepine acetate |
ES2903037T3 (en) | 2015-12-18 | 2022-03-30 | Jubilant Generics Ltd | Eslicarbazepine solid oral dosage forms |
CN106588773B (en) * | 2016-11-10 | 2019-09-27 | 北京现代药物代谢研究院 | A kind of Brain targeting eslicarbazepine ester prodrug and its application |
MX2021003730A (en) | 2018-09-28 | 2021-06-18 | Univ Griffith | Agents and methods for modulating pathogen activity. |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CH500196A (en) * | 1969-03-10 | 1970-12-15 | Ciba Geigy Ag | Process for the production of new azepine derivatives |
CH505101A (en) * | 1969-03-31 | 1971-03-31 | Ciba Geigy Ag | Process for the production of new azepine derivatives |
FI75561C (en) * | 1979-10-30 | 1988-07-11 | Ciba Geigy Ag | Process for the preparation of 5-carbamoyl-10-oxo-10,11-dihydro-5H-di benz / b, f / azepine and necessary intermediates thereto. |
CH649080A5 (en) * | 1981-04-16 | 1985-04-30 | Ciba Geigy Ag | 5H-DIBENZ (B, F) AZEPINE-5-CARBOXAMIDES AS A MEDICINE FOR PROPHYLAXIS AND TREATMENT OF CEREBRAL PERFORMANCE INSUFFICIENCY. |
DD218889B3 (en) * | 1983-11-09 | 1992-11-05 | Dresden Arzneimittel | PROCESS FOR PREPARING NEW 5-CARBAMOYL-10,11-DIHYDRO-5H-DIBENZ | B, FAZAZINE |
US5466683A (en) * | 1994-08-25 | 1995-11-14 | Teva Pharmaceutical Industries Ltd. | Water-soluble analogs of carbamazepine |
-
1995
- 1995-06-30 PT PT101732A patent/PT101732B/en not_active IP Right Cessation
-
1996
- 1996-06-27 US US08/673,819 patent/US5753646A/en not_active Expired - Lifetime
- 1996-06-27 HU HU9900172A patent/HU221382B1/en active Protection Beyond IP Right Term
- 1996-06-27 KR KR1019970709780A patent/KR100376603B1/en not_active IP Right Cessation
- 1996-06-27 TR TR97/01734T patent/TR199701734T1/en unknown
- 1996-06-27 PL PL96324313A patent/PL185476B1/en unknown
- 1996-06-27 AU AU63106/96A patent/AU705388B2/en not_active Expired
- 1996-06-27 RU RU98101463/04A patent/RU2168502C2/en active Protection Beyond IP Right Term
- 1996-06-27 CN CN96196397A patent/CN1070853C/en not_active Expired - Lifetime
- 1996-06-27 AR ARP960103352A patent/AR003962A1/en active IP Right Grant
- 1996-06-27 WO PCT/GB1996/001565 patent/WO1997002250A1/en active IP Right Grant
- 1996-06-28 SI SI9630030T patent/SI0751129T1/en unknown
- 1996-06-28 DK DK96110490.8T patent/DK0751129T6/en active
- 1996-06-28 ES ES96110490T patent/ES2124612T7/en active Active
- 1996-06-28 EP EP96110490.8A patent/EP0751129B3/en not_active Expired - Lifetime
- 1996-06-28 DE DE69600985.4T patent/DE69600985T3/en not_active Expired - Lifetime
- 1996-06-28 BR BRPI9602933A patent/BRPI9602933B8/en active IP Right Grant
- 1996-06-28 DE DE122009000049C patent/DE122009000049I2/en active Active
- 1996-06-28 AT AT96110490T patent/ATE173468T3/en unknown
- 1996-07-01 JP JP17146096A patent/JP3852984B2/en not_active Expired - Lifetime
- 1996-07-02 CA CA002180301A patent/CA2180301C/en not_active Expired - Lifetime
-
2003
- 2003-12-25 JP JP2003428815A patent/JP2004256516A/en active Pending
-
2009
- 2009-08-26 NL NL300406C patent/NL300406I1/en unknown
- 2009-08-26 FR FR09C0040C patent/FR09C0040I2/fr active Active